Pfizer To Seek Vax Approval For Children Over Five

The Guardian reports:

The German company BioNTech, which developed the Pfizer vaccine, expects to seek approval from regulators for Covid jabs suited for younger children as early as mid-October, its founders have said.

“Already over the next few weeks we will file the results of our trial in five- to 11-year-olds with regulators across the world and will request approval of the vaccine in this age group, also here in Europe,” BioNTech’s chief medical officer, Özlem Türeci, told the German news magazine Der Spiegel.

Türeci said her company was working on producing the vaccine, which was the same product being administered to adults and children aged 12 and older but in smaller doses.

Read the full article.

“There are around 60 days left for us as a society to avoid a hard winter,” said [BioNTech CEO Ugur] Şahin. “We should do everything possible to mobilise as many people as possible in the next two months.” https://t.co/uOte0Xh8Pp

— Meg Tirrell (@megtirrell) September 10, 2021